NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Coyote Biosciences Co., Ltd.

Business Name:
Coyote Biosciences Co., Ltd.
Business Genre:
Business Description:

Creates PCR-based disease diagnostics, emphasis on developing portable PCR technology for use in point-of-care facilities [2]

City:
San Jose
State:
CA
Data/Evidence of Effectiveness:
None available
Complimentary Products Needed to Perform Test:
Coyote Biosciences’ Mini8 Portable Molecular Diagnostic QPCR Station [3]
Setting of Care:
If EUA is granted, assumed to be clinical laboratories based on other PCR kit technologies, though Mini8 Portable Molecular Diagnostic QPCR Station is aimed at bringing PCR to point-of-care facilities [2].
Current Status / Clinical Development Stage / Expected Milestones:
As of 03/09/2020: “The test is reportedly being used as an RUO in China in more than 30 hospitals, 16 local CDC offices, and eight airports, and the firm has donated 500 instruments to Hubei province.” [3]
LOD:
Information not available
Funding & Ownership :
No information found
Business Model:
Coyote Biosciences develops PCR-based kits for detecion of numerous diseases, for use on their Mini8 Portable Molecular Diagnostic QPCR Station [4].
IP:
Multiple patents related to their PCR technology [5]
History & Origins :
Founded in 2009, with US headquarters established in 2015 [2]. Focused on developing poratble PCR technologies for disease diagnosis [2].
Date EUA Issued:
No EUA issued [1]
Sources:
[1]https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization [2]http://www.coyotebio.com/w83866.jsp [3]https://www.labmedica.com/covid-19/articles/294780864/global-coronavirus-crisis-researchers-industry-mobilize-to-offer-remedies-updated.html [4] http://www.coyotebio.com/c92298.jsp [5]https://patents.google.com/?assignee=coyote+bioscience+Co.
Organization:
No information found
No. Tests Per Day:
96 tests/run x 1 run/1 hour x 24 hours/day=2304 tests/day
Time to Result:
Results in 1 hour [3]
Test Sample Type:
Coyote Biosciences’ other PCR test kits accept “whole blood, serum, urine, or saliva samples,” [4] but it could be assumed that the 2019-nCoV assay will accept upper respiratory samples.
Technology Overview:
PCR-based nucleic acid detection using Coyote Biosciences’ “One-Step” molecular diagnostic method [2]
Testing Type:
RT-PCR based viral RNA test [3, 4]
Test Category:
RT-PCR
Test Name:
2019-nCoV Prep-Free QPCR Assay [3]
Clinical Application & Need:
Assumed to detect active infectious based on PCR technology used
Age of Company:
11 years old, founded in 2009. US headquarters are 5 years old, established in 2015 [2]

Send Message to listing owner

Leave A Reply